People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aquesys Inc | — | Biotechnology | Series B | $49.5M | $1.2B | 2010 |
Gregory Tammenoms Grunberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gregory Tammenoms Grunberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Milne | 1 | 7 |
| Ryan Schwarz | 1 | 7 |
| Anthony Lando | 1 | 6 |
| Juliet Tammenoms Bakker | 1 | 5 |
| Steven Waite | 1 | 4 |
| Michael Tyson | 1 | 2 |
| Andrew Corley | 1 | 2 |
| Julie Bakker | 1 | 1 |
| Michael Lee Tyson | 1 | 1 |
| Ron Bache | 1 | 1 |
| David Tammenoms Milne | 1 | 1 |
| Ryan Tammenoms Schwarz | 1 | 1 |
| Steven Tammenoms Waite | 1 | 1 |
| Edward Tammenoms Peterson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.